Results 11 to 20 of about 885,970 (344)

Seasonal influenza vaccine in immunocompromised persons

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Immunocompromised persons are at high risk of complications from influenza infection. This population includes those with solid organ transplants, hematopoietic stem cell transplants, solid cancers and hematologic malignancy as well as those with ...
Mohammad Bosaeed, Deepali Kumar
doaj   +2 more sources

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

open access: yesNature Network Boston, 2022
Currently, licensed seasonal influenza vaccines display variable vaccine effectiveness, and there remains a need for novel vaccine platforms capable of inducing broader responses against viral protein domains conserved among influenza subtypes.
Katherine V. Houser   +74 more
semanticscholar   +1 more source

Progress towards the Development of a Universal Influenza Vaccine

open access: yesViruses, 2022
Influenza viruses are responsible for millions of cases globally and significantly threaten public health. Since pandemic and zoonotic influenza viruses have emerged in the last 20 years and some of the viruses have resulted in high mortality in humans ...
Wen-Chien Wang   +3 more
semanticscholar   +1 more source

The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic

open access: yesVaccines, 2022
Vaccination to prevent influenza virus infection and to lessen its severity is recommended among healthcare workers (HCWs). Health professionals have a higher risk of exposure to viruses and could transmit the influenza virus to vulnerable patients who ...
Malik Sallam   +17 more
semanticscholar   +1 more source

Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis

open access: yesJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Influenza infection causes considerable morbidity and mortality in patients with cardiovascular disease. We assessed the effects of the influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease. Methods
Siva H. Yedlapati   +10 more
semanticscholar   +1 more source

Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis

open access: yesInfluenza and Other Respiratory Viruses, 2021
Standard‐dose seasonal influenza vaccines often produce modest immunogenic responses in adults ≥65 years old. MF59 is intended to elicit a greater magnitude and increased breadth of immune response.
B. Coleman   +3 more
semanticscholar   +1 more source

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

open access: yesVaccines, 2022
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups.
C. Trombetta   +4 more
semanticscholar   +1 more source

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine

open access: yesVaccines, 2021
Influenza virus has significant viral diversity, both through antigenic drift and shift, which makes development of a vaccine challenging. Current influenza vaccines are updated yearly to include strains predicted to circulate in the upcoming influenza ...
Brianna L. Bullard, E. Weaver
semanticscholar   +1 more source

Live attenuated influenza vaccine.

open access: yesCurrent Topics in Microbiology and Immunology, 2020
Cold-adapted Ann Arbor based live attenuated influenza vaccine (LAIV) has been available in the USA since 2003. The vaccine is efficacious against influenza infection.
Hong Jin, K. Subbarao
semanticscholar   +1 more source

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza

open access: yesnpj Vaccines, 2021
Recent approval of mRNA vaccines for emergency use against COVID-19 is likely to promote rapid development of mRNA-based vaccines targeting a wide range of infectious diseases.
Sudha Chivukula   +29 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy